Febuxostat (Form A) contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

非布索坦
Febuxostat

• 申請商: 宇直泰貿易股份有限公司
• 適應症: 高尿酸血症用藥
• 發證日期: 2020-08-13